Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,697.01
(
0.26%
)
News Focus
News Focus
Post# of 257265
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: oc631 post# 109949

Saturday, 12/04/2010 1:19:52 AM

Saturday, December 04, 2010 1:19:52 AM

Post# of 257265
My quote:

I'm not questioning the partnership with ItalFarmco. The approval of T-Lovenox not only would be a valuable asset for Teva but it's their chance to prove to the market they will be a leader in FOB. Besides Teva is too savvy to play the Lupenox game.




Why is it so implausible that Teva and ItalFarmco are working on a T-Lovenox program that has nothing to do with Lupenox? What about Teva's reputation?
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today